Skip to content

Efficacy of ropivacaine injection at acupoints for epidural analgesia for labor analgesia and its effect on immune function in parturients

Efficacy of ropivacaine injection at acupoints for epidural analgesia for labor analgesia and its effect on immune function in parturients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092969
Enrollment
Unknown
Registered
2024-11-26
Start date
2024-01-04
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

labor painia

Interventions

acupoint injection combined with epidural analgesia group (group O):Bilateral acupoint injection (Hegu, Sanyinjiao) of 0.1% ropivacaine+ Epidural analgesia
epidural analgesia group (group C):Epidural analgesia

Sponsors

Shaoxing Shangyu Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) American Society of Anesthesiologists (ASA) anesthesia classification: Grade I or II . (2)Singleton pregnancy at term. (3) Nullipara (37-42 weeks). (4) Cephalopelvic symmetry . (5) Estimated fetal weight 2kg-4kg. (6) No history of acupuncture treatment. (7) Suitable for vaginal delivery.

Exclusion criteria

Exclusion criteria: Anyone who meets any of the following criteria will be excluded: (1) Pregnant with multiple fetuses; (2) History of major cardiovascular or cerebrovascular diseases, combined with diabetes, hyperthyroidism, metabolic diseases, severe organ diseases, or mental illness; (3) Abnormal fetal position, abnormal placenta, or fetal distress in the uterus; (4) Contraindications to spinal anesthesia such as coagulation disorders, low platelet count, or spinal deformities; (5) Poor compliance from the patient, inability to cooperate, or refusal of acupuncture or epidural procedures; (6) Received acupuncture analgesia or sedative therapy during pregnancy.

Design outcomes

Primary

MeasureTime frame
Visual analogue scale (VAS) score ;modified Bromage score;postpartum hemorrhage (ml);The total dosage of ropivacaine;

Secondary

MeasureTime frame
Apgar score ;

Countries

China

Contacts

Public ContactJiang Jinjin

Department of Anesthesiology, Shaoxing Shangyu Maternal and Child Health Hospital

jin666368@163.com+86 135 6756 6368

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026